Annual Clinical and Scientific Conference 2018

June 26-29, 2018 in Victoria, British Columbia

Program is subject to changes.

Please note that events are taking place at a number of venues For easy reference, use this legend to help find your way:
V - Victoria Conference Centre
F -  Fairmont Empress
M - Victoria Marriott Inner Harbour

 

Photo of R. Douglas  Wilson

Biography

Dr. R. Douglas Wilson MD

Calgary AB
Present position:
Professor and Department Head Obstetrics and Gynecology
Coming School of Medicine University of Calgary
AHS Calgary Zone
Foothills Medical Center, Calgary Alberta Canada
December 2008 - present

Previous Academic Locations:
Children’s Hospital of Philadelphia, University of Pennsylvania
Philadelphia PA
Professor of Surgery / Obstetrics and Gynecology
Center for Fetal Diagnosis and Treatment
Hospital of the University of Pennsylvania
July 2001-November 2008

University of British Columbia, BC Children’s and Women’s
Hospital, Vancouver BC Canada
Professor of Obstetrics /Gynecology/ Medical Genetics
July1985-June2001

Educational sites:
Undergraduate: University of British Columbia BSc Chemistry 1971; MSc Genetics 1975
Medical: University of British Columbia 1977
Rotating Internship: Cook Hospital Gisborne NZ 1977-1978
Residency: University of British Columbia O/G 1979-1983
Fellowship: University of British Columbia
MFM/ Med Genetics 1983-1985

Academic and Research Interests: Prenatal Diagnosis (non-invasive; invasive); Fetal Therapy; Fetal Anomalies; Fetal Imaging; Prenatal Screening and Risk Reduction

Editorial Board: Fetal Diagnosis and Therapy; Clinical Genetics; Journal of Obstetrics and Gynecology Canada

Committee Chair: past SOGC Genetics Committee (1988-2016)

Academic Societies: SOGC, ACOG, ISPD, SMFM, AIUM, IFMSS, ASHG, Fetoscopy, Teratology

Disclosure

1. I do not have an affiliation (financial or otherwise) with a pharmaceutical, medical device or communications organization.

2. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).